Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HIV TREATMENT BASED ON INDIVIDUALIZED VIRAL BURDEN ANALYSIS

Executive Summary

HIV TREATMENT BASED ON INDIVIDUALIZED VIRAL BURDEN ANALYSIS warrants study, American Foundation, for AIDS Research Clinical Research Director Ellen Cooper, MD, said at a press roundtable on individualized HIV therapy sponsored by Hoffmann-La Roche and AmFAR in New York City July 12. "If you can monitor the viral Liter and intervene with a more effective drug or combination of drugs" when the Liter begins to rise, Cooper postulated, "you will be able to prolong the asymptomatic state."
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024781

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel